← Eichor
Condition: Neoadjuvant Immunotherapy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Neoadjuvant Immunotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of T
Phase 2 · 1 location(s) · Shengjing Hospital · NCT06165900Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07448142Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06571396Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Phase 2 · 1 location(s) · Xiaohua Wu · NCT06209294Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
NA · 1 location(s) · University of Wisconsin, Madison · NCT07343596Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05170503An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
NA · 1 location(s) · Peking Union Medical College Hospital · NCT07452003Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06705127Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Phase 1 · 1 location(s) · Inge Marie Svane · NCT07501117Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Manageme
Phase N/A · 4 location(s) · Peking University Cancer Hospital & Institute · NCT06926179De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyng
NA · 1 location(s) · Sun Yat-sen University · NCT06313450Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
Phase 2 · 1 location(s) · Jinhua Central Hospital · NCT06204094Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Phase 2 · 20 location(s) · UNICANCER · NCT05973864A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT07347951Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Phase 2 · 9 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT04617756Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophagea
Phase 2 · 1 location(s) · Second Affiliated Hospital of Zunyi Medical University · NCT07559045XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06902376Microbiome Immunotherapy Neoadjuvant Assessment
Phase N/A · 1 location(s) · University College Cork · NCT06709651Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)
Phase 3 · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06229041Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cance
Phase 2 · 1 location(s) · Qilu Hospital of Shandong University · NCT07537361Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
Phase 2 · 2 location(s) · Guangdong Association of Clinical Trials · NCT07120698Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
Phase 2 · 3 location(s) · Zhejiang Cancer Hospital · NCT05507411Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
Phase 3 · 1 location(s) · Qunxing Li,MD · NCT07371611Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
Phase 2 · 1 location(s) · Melanoma Institute Australia · NCT06999980Pembrolizumab in Locally Advanced Sinonasal Carcinoma
Phase 2 · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT05925491Durvalumab and Tremelimumab in Resectable HCC
Phase 2 · 3 location(s) · University Health Network, Toronto · NCT05440864The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06623487Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy
Phase 1/Phase 2 · 1 location(s) · Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. · NCT06880029
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.